BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24467262)

  • 1. Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists.
    Seipel AH; Delahunt B; Samaratunga H; Amin M; Barton J; Berney DM; Billis A; Cheng L; Comperat E; Evans A; Fine SW; Grignon D; Humphrey PA; Magi-Galluzzi C; Montironi R; Sesterhenn I; Srigley JR; Trpkov K; van der Kwast T; Varma M; Zhou M; Ahmad A; Moss S; Egevad L
    Histopathology; 2014 Aug; 65(2):216-27. PubMed ID: 24467262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.
    Seipel AH; Delahunt B; Samaratunga H; Egevad L
    Pathology; 2016 Aug; 48(5):398-405. PubMed ID: 27321992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.
    Seipel AH; Wiklund F; Wiklund NP; Egevad L
    Virchows Arch; 2013 Apr; 462(4):429-36. PubMed ID: 23443941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
    Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
    Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
    Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
    APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the diagnosis and management of ductal prostate cancer.
    Ranasinghe W; Shapiro DD; Zhang M; Bathala T; Navone N; Thompson TC; Broom B; Aparicio A; Tu SM; Tang C; Davis JW; Pisters L; Chapin BF
    Nat Rev Urol; 2021 Jun; 18(6):337-358. PubMed ID: 33824525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
    Rioux-Leclercq N; Leray E; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Epstein JI
    Hum Pathol; 2005 May; 36(5):531-5. PubMed ID: 15948120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
    Au S; Villamil CF; Alaghehbandan R; Wang G
    Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure prostatic papillary adenocarcinoma with ductal features.
    Yamashita S; Inaba Y; Soma F; Katayama Y
    Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma.
    Allam CK; Bostwick DG; Hayes JA; Upton MP; Wade GG; Domanowski GF; Klein MA; Boling EA; Stilmant MM
    Mod Pathol; 1996 Jul; 9(7):742-51. PubMed ID: 8832557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic ductal adenocarcinoma: a mini review.
    Epstein JI
    Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features.
    Fadare O; Parkash V; Dupont WD; Acs G; Atkins KA; Irving JA; Pirog EC; Quade BJ; Quddus MR; Rabban JT; Vang R; Hecht JL
    Am J Surg Pathol; 2012 Aug; 36(8):1107-18. PubMed ID: 22790851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations.
    Fine SW
    Adv Anat Pathol; 2012 Jul; 19(4):204-16. PubMed ID: 22692283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal adenocarcinoma of the prostate: Clinical and biological profiles.
    Vinceneux A; Bruyère F; Haillot O; Charles T; de la Taille A; Salomon L; Allory Y; Ouzaid I; Choudat L; Rouprêt M; Comperat E; Houede N; Beauval JB; Vourc'h P; Fromont G
    Prostate; 2017 Sep; 77(12):1242-1250. PubMed ID: 28699202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of Gleason grading among 337 European pathologists.
    Egevad L; Ahmad AS; Algaba F; Berney DM; Boccon-Gibod L; Compérat E; Evans AJ; Griffiths D; Grobholz R; Kristiansen G; Langner C; Lopez-Beltran A; Montironi R; Moss S; Oliveira P; Vainer B; Varma M; Camparo P
    Histopathology; 2013 Jan; 62(2):247-56. PubMed ID: 23240715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists.
    Varma M; Egevad L; Algaba F; Berney D; Bubendorf L; Camparo P; Comperat E; Erbersdobler A; Griffiths D; Grobholz R; Haitel A; Hulsbergen-van de Kaa C; Langner C; Loftus B; Lopez-Beltran A; Mayer N; Nesi G; Oliveira P; Oxley J; Rioux-Leclercq N; Seitz G; Shanks J; Kristiansen G
    J Clin Pathol; 2016 Oct; 69(10):852-7. PubMed ID: 26926101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Diagnosis of Intraductal Lesions of the Prostate.
    Wobker SE; Epstein JI
    Am J Surg Pathol; 2016 Jun; 40(6):e67-82. PubMed ID: 26848801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.